Mendoza, Lorecel M.

HRN: 21-40-90  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2022
CEFUROXIME 750MG (VIAL)
05/26/2022
06/02/2022
IVTT
750mg
Q8
Uti
Waiting Final Action 

Indication:      Type of Infection:      Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: